These pharmacies will be phased out by the state.

Guangdong pharmacies reported more than 1 billion it is reported that Guangdong is the third batch of state-reported amount of up to 2.6 billion, accounting for 11.2% of the country's share, is the country's largest reported province.
important reason for this is that Guangdong is one of the first provinces to implement simultaneous reporting of hospitals and pharmacies.
June this year, the Guangdong Provincial Health Insurance Bureau issued a notice that all private medical institutions and retail pharmacies can voluntarily participate in the third batch of centralized procurement of national drugs, pharmacies and non-public medical institutions logged on to the Guangdong Province drug trading platform for centralized reporting.
Guangdong Three Medicines Electronic Trading Management Co., Ltd. ("Guangdong Three Medicines") as a procurement complex, organize publicity and help retail pharmacies and non-public medical institutions to jointly study the reporting policy.
guangdong three medical related person-in-charge to SaiBaiLan said, for the national collection, Guangdong pharmacy enthusiasm is very high, but also attaches great importance to.
Because this is the first time that Guangdong pharmacies to participate in the national collection of the volume, most pharmacies do not have a very clear concept of the amount reported, so in the initial reporting, some large chains also specially organized to Guangdong three doctors to carry out the reporting consulting work, to study how to scientific reporting.
data show that a total of 28,000 pharmacy stores in Guangdong participated in the report, the amount of more than 1 billion yuan, accounting for nearly 40% of the total.
from the decline in drug prices, pending the formal implementation of the results, the participation in the amount of retail pharmacy procurement costs will be greatly reduced.
the highest reported of these varieties from the data level, Guangdong pharmacies reported large varieties of slow-disease drugs in the majority.
The largest amount of the reported amount is the non-tablets ofacid sidina, followed by the non-amine tablets, hydrochloric acid dapostin tablets, all three varieties of pharmacies are significantly higher than the hospital."
in pharmacy reports, Sidina is 1,522 times the hospital's, hydrochloric acid is 38 times the hospital's, and the non-nathamine tablets are 1.55 times the hospital's.
from the drug classification, all three drugs are used in male diseases.
is not used to treat penile erectile dysfunction (ED); dapoxitin is used to treat premature ejaculation in men; and non-amine is used to treat prostate hyperplision.
Fact, Guangdong is the leading country in the number of such drugs reported, and can not directly blame Guangdong men for the need to use such drugs, retail pharmacies involved in reporting is also one of the reasons.
, for example, the retail market is much larger than the hospital market.
2019, the size of the national retail market in Xidinafei was 2.37 billion yuan, while the size of the national hospital market was only 120 million yuan, according to Mina.com.
(Source: Minernet) On the reasons why the gap between the retail and hospital markets is so large, Wu Jieping, head of guangzhou Zhengkang chain pharmacy, told SaibaiLan, mainly because male patients for various reasons prefer to buy drugs in pharmacies for self-medication, rather than preferred hospitals.
, for example, Indyna, many hospitals are very little or no goods, because many people with ED also do not want to go to the hospital, will go to the nearest pharmacy to buy medicine to solve.
, there are people who don't get sick and go to pharmacies to buy the drug, which is why it sells so much in retail pharmacies.
market competition pattern to meet the dramatic changes in the impact of national collection is not only pharmaceutical enterprises, this Guangdong pharmacy into the collection, will bring a huge impact on the retail pharmacy market.
understand that at present, about half of Guangdong pharmacies involved in the national collection, of which chains accounted for the vast majority, the proportion of single pharmacies less than 4%.
nearly half of all drugstores that do not report, the vast majority are monos.
, Guangdong three medical related person-in-charge told SaibaiLan, based on past experience, not participating in the amount of retail pharmacies will be difficult to obtain varieties, in the future competition at a disadvantage.
with the continuous expansion of the scope of collection, information continues to be transparent, not participating in the collection of single pharmacies will face huge competitive pressure and customer loss, and may eventually face the market elimination of the situation.
that the retail pharmacy industry will further intensify the chaining process in the future.
that the state does not have a zero-plus requirement for pharmacies to participate in collection, so pharmacies can enjoy free pricing.
but this report to participate in a lot of pharmacies, market competition is expected to be very full.
certainly does not rule out that in the early days, some pharmacies will maintain the original price for sale in the case of information asymmetry.
but with the market competition gradually full, coupled with the hospital's zero-plus price, drugstores in the purchase price of large price increases are unlikely to sell.
is more likely to see a significant drop in the prices of collected varieties, which will be mainly used as pharmacy diversion varieties.
on the issue of prices, the above-mentioned pharmacy officials also pointed out that hospitals implement zero price increases for medicines, the purchase price of drugs is the price patients need to pay.
But pharmacies are not the same, pharmacies need to be profitable, because the collection price is very low, to give pharmacies a lower profit margin, so the national collection varieties for pharmacies, is not a profitable varieties, but mainly as a diversion of goods.
varieties as a means of draining, and then with high-hair varieties and quality services will become the main means of pharmacy operation.
balance between drains, profits and services is a question worthy of deep consideration by retail pharmacies.
Through this collection of Guangdong pharmacies reported large varieties, we can also find that the core category of pharmacy procurement to slow disease category- mainly, this type of patients need long-term medication, but also need scientific control and health conditioning, pharmacies can use their geographical advantages, do a good job of pharmacy services, so as to retain this part of the customer.
with the expansion of the scope of collection, will promote the transformation and upgrading of pharmacies, improve their own service capabilities, do a good job in category management and patient health services.
.